PRECIPIO, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
PRECIPIO, INC. (PRPO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$2.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-30
- PRECIPIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$2.20M, a 269.23% decline from fiscal 2024.
- PRECIPIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.30M, a 7.14% decline from fiscal 2023.
- PRECIPIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.40M, a 58.82% decline from fiscal 2022.
- PRECIPIO, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $3.40M, a 100.00% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | -$2.20M 10-K · filed 2026-03-30 |
| 2024-12-31 | $1.30M 10-K · filed 2026-03-30 |
| 2023-12-31 | $1.40M 10-K · filed 2025-03-27 |
| 2022-12-31 | $3.40M 10-K · filed 2024-03-29 |
| 2021-12-31 | $1.70M 10-K · filed 2023-03-30 |
| 2020-12-31 | $2.80M 10-K · filed 2022-03-30 |
| 2019-12-31 | $1.90M 10-K · filed 2021-03-29 |
| 2018-12-31 | $7.00M 10-K · filed 2019-04-16 |
| 2017-12-31 | $1.10M 10-K · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |